In drug delivery, silk fibroin nanoparticles can be engineered to encapsulate a variety of therapeutic agents, including small molecule drugs, proteins, and even genes. The release profile of these drugs can be finely tuned by modifying the silk fibroin matrix. This makes it possible to achieve sustained and controlled release, enhancing the efficacy and reducing the side effects of the drugs.
